과제정보
This work was supported by a National Research Foundation of Korea (NRF) Grants (2022R1F1A1074216, 2020M3E5D9080165) funded by the Korea government (MSIT).
참고문헌
- Berchiche, Y.A. and Sakmar, T.P. (2016). CXC chemokine receptor 3 alternative splice variants selectively activate different signaling pathways. Mol. Pharmacol. 90, 483-495. https://doi.org/10.1124/mol.116.105502
- Bodnar, R.J. (2015). Chemokine regulation of angiogenesis during wound healing. Adv. Wound Care (New Rochelle) 4, 641-650. https://doi.org/10.1089/wound.2014.0594
- Cheng, Z., Garvin, D., Paguio, A., Stecha, P., Wood, K., and Fan, F. (2010). Luciferase reporter assay system for deciphering GPCR pathways. Curr. Chem. Genomics 4, 84-91. https://doi.org/10.2174/1875397301004010084
- Clark-Lewis, I., Mattioli, I., Gong, J.H., and Loetscher, P. (2003). Structure-function relationship between the human chemokine receptor CXCR3 and its ligands. J. Biol. Chem. 278, 289-295. https://doi.org/10.1074/jbc.M209470200
- Cole, K.E., Strick, C.A., Paradis, T.J., Ogborne, K.T., Loetscher, M., Gladue, R.P., Lin, W., Boyd, J.G., Moser, B., Wood, D.E., et al. (1998). Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187, 2009-2021. https://doi.org/10.1084/jem.187.12.2009
- Ehlert, J.E., Addison, C.A., Burdick, M.D., Kunkel, S.L., and Strieter, R.M. (2004). Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. J. Immunol. 173, 6234-6240. https://doi.org/10.4049/jimmunol.173.10.6234
- Eisman, R., Surrey, S., Ramachandran, B., Schwartz, E., and Poncz, M. (1990). Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. Blood 76, 336-344. https://doi.org/10.1182/blood.V76.2.336.336
- Farber, J.M. (1997). Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61, 246-257. https://doi.org/10.1002/jlb.61.3.246
- Files, J.C., Malpass, T.W., Yee, E.K., Ritchie, J.L., and Harker, L.A. (1981). Studies of human plate alpha-granule release in vivo. Blood 58, 607-618. https://doi.org/10.1182/blood.V58.3.607.607
- Fleischer, J., Grage-Griebenow, E., Kasper, B., Heine, H., Ernst, M., Brandt, E., Flad, H.D., and Petersen, F. (2002). Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J. Immunol. 169, 770-777. https://doi.org/10.4049/jimmunol.169.2.770
- Groom, J.R. and Luster, A.D. (2011). CXCR3 ligands: redundant, collaborative and antagonistic functions. Immunol. Cell Biol. 89, 207-215. https://doi.org/10.1038/icb.2010.158
- Harding, P.J., Attrill, H., Boehringer, J., Ross, S., Wadhams, G.H., Smith, E., Armitage, J.P., and Watts, A. (2009). Constitutive dimerization of the G-protein coupled receptor, neurotensin receptor 1, reconstituted into phospholipid bilayers. Biophys. J. 96, 964-973. https://doi.org/10.1016/j.bpj.2008.09.054
- Harmon, B.T., Orkunoglu-Suer, E.F., Adham, K., Larkin, J.S., Gordish-Dressman, H., Clarkson, P.M., Thompson, P.D., Angelopoulos, T.J., Gordon, P.M., Moyna, N.M., et al. (2010). CCL2 and CCR2 variants are associated with skeletal muscle strength and change in strength with resistance training. J. Appl. Physiol. (1985) 109, 1779-1785. https://doi.org/10.1152/japplphysiol.00633.2010
- Heise, C.E., Pahuja, A., Hudson, S.C., Mistry, M.S., Putnam, A.L., Gross, M.M., Gottlieb, P.A., Wade, W.S., Kiankarimi, M., Schwarz, D., et al. (2005). Pharmacological characterization of CXC chemokine receptor 3 ligands and a small molecule antagonist. J. Pharmacol. Exp. Ther. 313, 1263-1271. https://doi.org/10.1124/jpet.105.083683
- Jean-Charles, P.Y., Kaur, S., and Shenoy, S.K. (2017). G protein-coupled receptor signaling through β-arrestin-dependent mechanisms. J. Cardiovasc. Pharmacol. 70, 142-158. https://doi.org/10.1097/FJC.0000000000000482
- Kasper, B., Brandt, E., Brandau, S., and Petersen, F. (2007). Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J. Immunol. 179, 2584-2591. https://doi.org/10.4049/jimmunol.179.4.2584
- Kawada, K., Sonoshita, M., Sakashita, H., Takabayashi, A., Yamaoka, Y., Manabe, T., Inaba, K., Minato, N., Oshima, M., and Taketo, M.M. (2004). Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Res. 64, 4010-4017. https://doi.org/10.1158/0008-5472.CAN-03-1757
- Kuang, Y., Wu, Y., Jiang, H., and Wu, D. (1996). Selective G protein coupling by CC chemokine receptors (*). J. Biol. Chem. 271, 3975-3978. https://doi.org/10.1074/jbc.271.8.3975
- Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., et al. (2003). An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 1537-1549. https://doi.org/10.1084/jem.20021897
- Li, H., Rong, S., Chen, C., Fan, Y., Chen, T., Wang, Y., Chen, D., Yang, C., and Yang, J. (2019). Disparate roles of CXCR3A and CXCR3B in regulating progressive properties of colorectal cancer cells. Mol. Carcinog. 58, 171-184. https://doi.org/10.1002/mc.22917
- Li, Z., Liu, J., Li, L., Shao, S., Wu, J., Bian, L., and He, Y. (2018). Epithelial mesenchymal transition induced by the CXCL9/CXCR3 axis through AKT activation promotes invasion and metastasis in tongue squamous cell carcinoma. Oncol. Rep. 39, 1356-1368.
- Loetscher, M., Gerber, B., Loetscher, P., Jones, S.A., Piali, L., Clark-Lewis, I., Baggiolini, M., and Moser, B. (1996). Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J. Exp. Med. 184, 963-969. https://doi.org/10.1084/jem.184.3.963
- Lord, M.S., Cheng, B., Farrugia, B.L., McCarthy, S., and Whitelock, J.M. (2017). Platelet factor 4 binds to vascular proteoglycans and controls both growth factor activities and platelet activation. J. Biol. Chem. 292, 4054-4063. https://doi.org/10.1074/jbc.M116.760660
- Marti, F., Bertran, E., Llucia, M., Villen, E., Peiro, M., Garcia, J., and Rueda, F. (2002). Platelet factor 4 induces human natural killer cells to synthesize and release interleukin-8. J. Leukoc. Biol. 72, 590-597. https://doi.org/10.1189/jlb.72.3.590
- Mueller, A., Meiser, A., McDonagh, E.M., Fox, J.M., Petit, S.J., Xanthou, G., Williams, T.J., and Pease, J.E. (2008). CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. J. Leukoc. Biol. 83, 875-882. https://doi.org/10.1189/jlb.1006645
- Nehme, R., Carpenter, B., Singhal, A., Strege, A., Edwards, P.C., White, C.F., Du, H., Grisshammer, R., and Tate, C.G. (2017). Mini-G proteins: novel tools for studying GPCRs in their active conformation. PLoS One 12, e0175642.
- Neptune, E.R. and Bourne, H.R. (1997). Receptors induce chemotaxis by releasing the betagamma subunit of Gi, not by activating Gq or Gs. Proc. Natl. Acad. Sci. U. S. A. 94, 14489-14494. https://doi.org/10.1073/pnas.94.26.14489
- Nguyen, H.T., Reyes-Alcaraz, A., Yong, H.J., Nguyen, L.P., Park, H.K., Inoue, A., Lee, C.S., Seong, J.Y., and Hwang, J.I. (2020a). CXCR7: a β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2. Cell Biosci. 10, 134.
- Nguyen, L.P., Nguyen, H.T., Yong, H.J., Reyes-Alcaraz, A., Lee, Y.N., Park, H.K., Na, Y.H., Lee, C.S., Ham, B.J., Seong, J.Y., et al. (2020b). Establishment of a NanoBiT-based cytosolic Ca(2+) sensor by optimizing calmodulin-binding motif and protein expression levels. Mol. Cells 43, 909-920. https://doi.org/10.14348/molcells.2020.0144
- Ohmori, Y., Wyner, L., Narumi, S., Armstrong, D., Stoler, M., and Hamilton, T.A. (1993). Tumor necrosis factor-alpha induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am. J. Pathol. 142, 861-870.
- Rajagopalan, L. and Rajarathnam, K. (2006). Structural basis of chemokine receptor function-a model for binding affinity and ligand selectivity. Biosci. Rep. 26, 325-339. https://doi.org/10.1007/s10540-006-9025-9
- Reynders, N., Abboud, D., Baragli, A., Noman, M.Z., Rogister, B., Niclou, S.P., Heveker, N., Janji, B., Hanson, J., Szpakowska, M., et al. (2019). The distinct roles of CXCR3 variants and their ligands in the tumor microenvironment. Cells 8, 613.
- Rosenkilde, M.M., McLean, K.A., Holst, P.J., and Schwartz, T.W. (2004). The CXC chemokine receptor encoded by herpesvirus saimiri, ECRF3, shows ligand-regulated signaling through Gi, Gq, and G12/13 proteins but constitutive signaling only through Gi and G12/13 proteins. J. Biol. Chem. 279, 32524-32533. https://doi.org/10.1074/jbc.M313392200
- Schenk, B.I., Petersen, F., Flad, H.D., and Brandt, E. (2002). Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J. Immunol. 169, 2602-2610. https://doi.org/10.4049/jimmunol.169.5.2602
- Shi, G., Partida-Sanchez, S., Misra, R.S., Tighe, M., Borchers, M.T., Lee, J.J., Simon, M.I., and Lund, F.E. (2007). Identification of an alternative Gαq-dependent chemokine receptor signal transduction pathway in dendritic cells and granulocytes. J. Exp. Med. 204, 2705-2718. https://doi.org/10.1084/jem.20071267
- Shin, S.Y., Nam, J.S., Lim, Y., and Lee, Y.H. (2010). TNFalpha-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. J. Biol. Chem. 285, 30731-30740. https://doi.org/10.1074/jbc.M110.128124
- Smith, J.S., Alagesan, P., Desai, N.K., Pack, T.F., Wu, J.H., Inoue, A., Freedman, N.J., and Rajagopal, S. (2017). C-X-C motif chemokine receptor 3 splice variants differentially activate beta-arrestins to regulate downstream signaling pathways. Mol. Pharmacol. 92, 136-150. https://doi.org/10.1124/mol.117.108522
- Springael, J.Y., Urizar, E., and Parmentier, M. (2005). Dimerization of chemokine receptors and its functional consequences. Cytokine Growth Factor Rev. 16, 611-623. https://doi.org/10.1016/j.cytogfr.2005.05.005
- Szpakowska, M., Fievez, V., Arumugan, K., Van Nuland, N., Schmit, J.C., and Chevigne, A. (2012). Function, diversity and therapeutic potential of the N-terminal domain of human chemokine receptors. Biochem. Pharmacol. 84, 1366-1380. https://doi.org/10.1016/j.bcp.2012.08.008
- Terrillon, S. and Bouvier, M. (2004). Roles of G-protein-coupled receptor dimerization: from ontogeny to signalling regulation. EMBO Rep. 5, 30-34. https://doi.org/10.1038/sj.embor.7400052
- Thomas, S.Y., Hou, R., Boyson, J.E., Means, T.K., Hess, C., Olson, D.P., Strominger, J.L., Brenner, M.B., Gumperz, J.E., Wilson, S.B., et al. (2003). CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171, 2571-2580. https://doi.org/10.4049/jimmunol.171.5.2571
- Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M.D., Soni, S., McSkane, M., Baba, H., and Lenz, H.J. (2018). CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy. Cancer Treat. Rev. 63, 40-47. https://doi.org/10.1016/j.ctrv.2017.11.007
- Wan, Q., Okashah, N., Inoue, A., Nehme, R., Carpenter, B., Tate, C.G., and Lambert, N.A. (2018). Mini G protein probes for active G protein-coupled receptors (GPCRs) in live cells. J. Biol. Chem. 293, 7466-7473. https://doi.org/10.1074/jbc.RA118.001975
- Wang, C.J., Hsu, S.H., Hung, W.T., and Luo, C.W. (2009). Establishment of a chimeric reporting system for the universal detection and high-throughput screening of G protein-coupled receptors. Biosens. Bioelectron. 24, 2298-2304. https://doi.org/10.1016/j.bios.2008.11.023
- Weng, Y., Siciliano, S.J., Waldburger, K.E., Sirotina-Meisher, A., Staruch, M.J., Daugherty, B.L., Gould, S.L., Springer, M.S., and DeMartino, J.A. (1998). Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J. Biol. Chem. 273, 18288-18291. https://doi.org/10.1074/jbc.273.29.18288
- Windmuller, C., Zech, D., Avril, S., Boxberg, M., Dawidek, T., Schmalfeldt, B., Schmitt, M., Kiechle, M., and Bronger, H. (2017). CXCR3 mediates ascites-directed tumor cell migration and predicts poor outcome in ovarian cancer patients. Oncogenesis 6, e331.
- Wu, Q., Dhir, R., and Wells, A. (2012). Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion. Mol. Cancer 11, 3.
- Yagi, H., Tan, W., Dillenburg-Pilla, P., Armando, S., Amornphimoltham, P., Simaan, M., Weigert, R., Molinolo, A.A., Bouvier, M., and Gutkind, J.S. (2011). A synthetic biology approach reveals a CXCR4-G13-Rho signaling axis driving transendothelial migration of metastatic breast cancer cells. Sci. Signal. 4, ra60.
- Yamamoto, J., Adachi, Y., Onoue, Y., Adachi, Y.S., Okabe, Y., Itazawa, T., Toyoda, M., Seki, T., Morohashi, M., Matsushima, K., et al. (2000). Differential expression of the chemokine receptors by the Th1- and Th2-type effector populations within circulating CD4+ T cells. J. Leukoc. Biol. 68, 568-574.
- Yang, C., Zheng, W., and Du, W. (2016). CXCR3A contributes to the invasion and metastasis of gastric cancer cells. Oncol. Rep. 36, 1686-1692. https://doi.org/10.3892/or.2016.4953
- Zipin-Roitman, A., Meshel, T., Sagi-Assif, O., Shalmon, B., Avivi, C., Pfeffer, R.M., Witz, I.P., and Ben-Baruch, A. (2007). CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. Cancer Res. 67, 3396-3405. https://doi.org/10.1158/0008-5472.CAN-06-3087